16752172

Source:http://linkedlifedata.com/resource/pubmed/id/16752172

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010181, umls-concept:C0011847, umls-concept:C0220908
pubmed:issue	7
pubmed:dateCreated	2006-6-5
pubmed:abstractText	The cost-effectiveness of screening for diabetes is unknown but has been modelled previously. None of these models has taken account of uncertainty. We aimed to describe these uncertainties in a model where the outcome was CHD risk.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0006777
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0012-186X
pubmed:author	pubmed-author:FarewellDD, pubmed-author:GlümerCC, pubmed-author:GriffinSS, pubmed-author:KinmonthA LAL, pubmed-author:SpiegelhalterDD, pubmed-author:WarehamN JNJ, pubmed-author:YuyunMM
pubmed:issnType	Print
pubmed:volume	49
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1536-44
pubmed:meshHeading	pubmed-meshheading:16752172-Adult, pubmed-meshheading:16752172-Cost-Benefit Analysis, pubmed-meshheading:16752172-Diabetes Mellitus, Type 2, pubmed-meshheading:16752172-Female, pubmed-meshheading:16752172-Humans, pubmed-meshheading:16752172-Male, pubmed-meshheading:16752172-Mass Screening, pubmed-meshheading:16752172-Middle Aged, pubmed-meshheading:16752172-Models, Theoretical, pubmed-meshheading:16752172-Monte Carlo Method, pubmed-meshheading:16752172-Sensitivity and Specificity
pubmed:year	2006
pubmed:articleTitle	What determines the cost-effectiveness of diabetes screening?
pubmed:affiliation	Medical Research Council Epidemiology Unit, Elsie Widdowson Laboratories, 120 Fulbourn Road, Cambridge, CB1 9NL, UK.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies